Carna Biosciences, Inc.
Notice of Completion of Payment for the 5th Unsecured Convertible Bond with Stock Acquisition Rights of Carna Biosciences, Inc.
Announces completion of payment for warrants-attached convertible bonds. The 5th unsecured convertible bond with stock acquisition rights totals 187,200,000 yen, interest rate 1.0% per annum, maturity date November 2, 2029, and potential shares amount to 687,830 shares. Allottee is Cantor Fitzgerald Europe. Third-party allotment of warrants-attached bonds and new shares was executed.
Key Figures
- 187,200,000 yen: Total amount of bonds
- 40 units: Total number of warrants
- 687,830 shares: Potential number of shares
AI要約
Overview
Carna Biosciences, Inc. announced the completion of payment for the 5th unsecured convertible bond with stock acquisition rights issued by third-party allotment. The allottee is Cantor Fitzgerald Europe, and the total amount is 187,200,000 yen. There are 40 warrants, corresponding to 687,830 potential shares upon conversion. The interest rate is 1.0% per annum and the maturity date is November 2, 2029.
Allottee, Procedures and Future Actions
The issuance of the warrants-attached convertible bonds was conducted as a third-party allotment under the warrants-attached bond issuance program agreement, with Cantor Fitzgerald Europe as the allottee. The conversion price for the warrants is 302.4 yen, and no price adjustment clause is attached. Payment has been completed; note that any future financing cycles or additional financings will require approval from the allottee.
Carna Biosciences, Inc.
Company overview · Stock price · Financial data · All IR
